Post: Director of Formulations and Manufacturing Shares Successful Case Study: Rapid, Science-Driven Success in Early Phase Pharmaceutical Development.

QCL demonstrates success in early phase pharmaceutical development. Dr Emily Ware, Director of Formulations and Manufacturing at QCL, and lead formulation Scientist, Robert Sciscento developed two dosage types avoiding first-pass metabolism in the gut. The lead dosage form was prepared for First in Human trials within 6 months of project inception. Read full case study for additional details.

Read Full Article

Want to collaborate on an upcoming project?

Leave your details and a team member will get back to you shortly.